Latent membrane protein-specific cytotoxic T lymphocytes: new hope for patients with natural killer/T-cell lymphoma?
作者信息
Yuan Shunzong, Su Hang
机构信息
Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
出版信息
J Clin Oncol. 2014 Sep 1;32(25):2819-20. doi: 10.1200/JCO.2014.56.3551. Epub 2014 Jul 21.
PMID:25049331
Abstract
摘要
相似文献
1
Latent membrane protein-specific cytotoxic T lymphocytes: new hope for patients with natural killer/T-cell lymphoma?
J Clin Oncol. 2014 Sep 1;32(25):2819-20. doi: 10.1200/JCO.2014.56.3551. Epub 2014 Jul 21.
2
Targeting Epstein-Barr virus-associated lymphomas.
J Clin Oncol. 2014 Mar 10;32(8):830-2. doi: 10.1200/JCO.2013.53.2994. Epub 2014 Feb 3.
3
Reply to S. Yuan et al.对S. 袁等人的回复
J Clin Oncol. 2014 Sep 1;32(25):2820-1. doi: 10.1200/JCO.2014.56.8469. Epub 2014 Jul 21.
4
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.用于爱泼斯坦-巴尔病毒相关淋巴瘤患者的、针对潜伏膜蛋白（LMP）-1和LMP2的药品生产质量管理规范级细胞毒性T淋巴细胞。
Cytotherapy. 2011 May;13(5):518-22. doi: 10.3109/14653249.2011.561983. Epub 2011 Mar 1.
5
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.接受针对 Epstein-Barr 病毒潜伏膜蛋白的自体细胞毒性 T 淋巴细胞治疗的淋巴瘤患者获得持续完全缓解。
J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.
6
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
Clin Lymphoma Myeloma. 2006 Jan;6(4):342-7. doi: 10.3816/CLM.2006.n.011.
7
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.肿瘤抗原呈递细胞基因改造及T淋巴细胞转移后复发淋巴瘤的完全缓解
Blood. 2007 Oct 15;110(8):2838-45. doi: 10.1182/blood-2007-05-091280. Epub 2007 Jul 3.
8
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.针对爱泼斯坦-巴尔病毒阳性霍奇金淋巴瘤的细胞毒性T淋巴细胞疗法。
J Exp Med. 2004 Dec 20;200(12):1623-33. doi: 10.1084/jem.20040890.
9
Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.用于过继性免疫治疗的EBV特异性T细胞的产生：一种使用福尔马林固定刺激细胞提高生物安全性的新方案。
J Immunother. 2007 Nov-Dec;30(8):817-24. doi: 10.1097/CJI.0b013e318155a11c.
10
引用本文的文献
1
Reply to S. Yuan et al.对S. 袁等人的回复
J Clin Oncol. 2014 Sep 1;32(25):2820-1. doi: 10.1200/JCO.2014.56.8469. Epub 2014 Jul 21.
Zotero 插件